| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6177486 | European Urology | 2016 | 11 Pages |
Abstract
We synthesized the evidence available about the early administration of docetaxel in patients starting hormonal treatment for metastatic prostate cancer. Based on the results of this meta-analysis, we believe the combination of chemotherapy and hormonal treatment should be considered in fit patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Marcello Tucci, Valentina Bertaglia, Francesca Vignani, Consuelo Buttigliero, Cristian Fiori, Francesco Porpiglia, Giorgio Vittorio Scagliotti, Massimo Di Maio,